Silence Therapeutics (SLN)
NASDAQ: SLN
· Real-Time Price · USD
5.00
-0.14 (-2.72%)
At close: Sep 25, 2025, 3:59 PM
5.00
0.00%
After-hours: Sep 25, 2025, 04:10 PM EDT
-2.72% (1D)
| Bid | 4.65 |
| Market Cap | 236.17M |
| Revenue (ttm) | 25.84M |
| Net Income (ttm) | -68.72M |
| EPS (ttm) | -1.68 |
| PE Ratio (ttm) | -2.98 |
| Forward PE | -9.72 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 5.3 |
| Volume | 43,463 |
| Avg. Volume (20D) | 73,912 |
| Open | 5.19 |
| Previous Close | 5.14 |
| Day's Range | 4.90 - 5.19 |
| 52-Week Range | 1.97 - 20.48 |
| Beta | 1.38 |
| Ex-Dividend Date | n/a |
Analyst Forecast
According to 0 analyst ratings, the average rating for SLN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsSilence Therapeutics is scheduled to release its earnings on
Nov 13, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
7 months ago
-15.45%
Silence Therapeutics shares are trading lower afte...
Unlock content with
Pro Subscription
